Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $1.09 Million - $1.21 Million
11,500 New
11,500 $1.17 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $226,650 - $277,560
3,000 New
3,000 $272,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $3.25 Million - $3.83 Million
-38,900 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $3.33 Million - $3.67 Million
38,900 New
38,900 $3.38 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.